HOME >> BIOLOGY >> NEWS
Einstein's Dr. Vern Schramm elected to the National Academy of Sciences

May 1, 2007 (BRONX, NY) -- Vern L. Schramm, Ph.D., Professor and Ruth Merns Chair of Biochemistry at the Albert Einstein College of Medicine of Yeshiva University, has been elected to the National Academy of Sciences, the nations most prestigious honorary society for scientists. His election was announced today at the Academys annual meeting in Washington, D.C.

Dr. Schramm has been a member of the Einstein faculty since 1987. Throughout his career, he has carried out groundbreaking research into the mechanisms involved in enzymatic reactions. This work has led to promising drugs now being tested in clinical trials for treating autoimmune diseases and several types of cancer.

Dr. Schramm studies the transition-state structure of enzyme-catalyzed reactions the shapes that reacting molecules assume when enzymes catalyze chemical reactions. As he describes it, Enzymes govern virtually all of the chemical transformations necessary for biological life but can also influence cells to become cancerous. By knowing the transition-state structure of enzyme-catalyzed reactions, we can design powerful inhibitors that can block those enzymes from acting and thereby treat or prevent cancer and other diseases.

One such inhibitor that Dr. Schramm has designed, known as Immucillin-H, is a promising anticancer agent for treating T-cell malignancies. It is currently in a pivotal phase IIb clinical trial (specifically targeted to study efficacy) at sites in the U.S., eastern and western Europe, and South America.

Another transition-state inhibitor developed by Dr. Schramm is now being studied as a possible treatment for autoimmune diseases such as psoriasis, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disorders and for preventing the rejection of transplanted organs.

The election to the Academy is the latest among numerous honors recognizing Dr. Schramms many contributions in more than 35 years as a biochemistr
'"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
4-May-2007


Page: 1 2

Related biology news :

1. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
2. Einsteins Susan Band Horwitz, PhD wins Bristol-Myers Squibb Cancer Research Award
3. Candidate research sites selected for the National Ecological Observatory Network
4. Depiction of findings selected as 2007 Image of the Year by Society for Nuclear Medicine
5. CSHL selected for odENCODE Data Coordination Center
6. University of Arizona neurobiologist John Hildebrand elected to the National Academy of Sciences
7. 5 Stanford professors elected to National Academy of Sciences
8. Salk scientist Ursula Bellugi elected to National Academy of Sciences
9. Psychology professor elected to American Academy of Arts and Sciences
10. ORNLs Thundat elected fellow of AAAS
11. Leading scientists elected to EMBO ranks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... ... February 13, 2020 , ... Worldwide Business ... Nobio CEO Yoram Ashery to discuss how their revolutionary technology can kill ... bacteria to keep people healthy with their revolutionary nanoparticle technology. Nobio is on ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... The LaunchPort™ medical device accelerator in Port Covington, Baltimore. The newly formed company ... must be addressed to manage increased demand for home dialysis treatments. The start-up ...
(Date:2/6/2020)... NEW YORK (PRWEB) , ... ... ... global, full-service clinical research organization (CRO) specializing in complex interventional medical device ... as Vice President, Regulatory Strategy. In this newly established role, Dorothy oversees ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced ... The new Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ ... saliva, researchers can extend the accuracy and ease of use of salivary bioscience ...
(Date:1/24/2020)... SOUTH RIDING, Va. (PRWEB) , ... January 24, ... ... analytics, and other innovations created by companies in biotechnology, diagnostics, therapeutics, laboratory and ... the lives of millions of people around the world. And as Slone ...
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group LLC (MDG) ... Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners ... over 30 years of sales experience working across multiple different market sectors such ...
(Date:1/10/2020)... ... January 09, 2020 , ... Phlexglobal, the leading provider ... of Cunesoft, a move that expands the company’s portfolio of best-of-breed technologies designed ... , Based in Munich, Germany, Cunesoft provides intelligent software and expert services for ...
Breaking Biology Technology:
Cached News: